Publications by authors named "Batelaan N"

Background: This scoping review focuses on the occurrence of tachyphylaxis, defined as reduced responsiveness upon reinitiating a previously effective medication. This phenomenon is previously documented in antidepressants and mood stabilizers.

Aim: To explore the frequency, treatment strategies, and predictability of tachyphylaxis across all psychotropic medications.

View Article and Find Full Text PDF
Article Synopsis
  • This study explores how brain activation during symptom provocation tasks can predict the effectiveness of a combined treatment of rTMS and ERP for patients with treatment-resistant OCD.
  • Sixty-one adults with OCD participated in fMRI scans to measure brain activity in response to OCD-related stimuli before undergoing an 8-week treatment regimen, with multiple rTMS applied to different brain areas.
  • Results indicated that higher activation in the right amygdala prior to treatment was associated with a better response to therapy, while activation in the dorsal anterior cingulate cortex had a negative association with treatment outcomes.
View Article and Find Full Text PDF

Background: Non-invasive brain stimulation, such as repetitive transcranial magnetic stimulation (rTMS), is increasingly used in the treatment of neurological diseases and psychiatric disorders. Where rTMS is already an accepted treatment option for depression, in the Netherlands/Belgium, no consensus exist on the application of rTMS for (obsessive-compulsive disorder (OCD). People with OCD who do not respond enough to exposure therapy and serotonergic antidepressants are in great need for treatment alternatives.

View Article and Find Full Text PDF
Article Synopsis
  • Mood and anxiety disorders can affect people in different ways, and researchers studied how these conditions change over time.
  • They looked at data from a survey of thousands of adults over several years to find out about different types of mood and anxiety disorders.
  • They discovered four main groups of people, with most being healthy, while those with panic and phobia disorders tended to stay unwell longer and may need more help.
View Article and Find Full Text PDF

Background: Repetitive transcranial magnetic stimulation (rTMS) has the potential to increase the clinical effect of exposure with response prevention psychotherapy for obsessive-compulsive disorder (OCD). We investigated the use of task-based functional magnetic resonance imaging for predicting clinical outcomes to different rTMS protocols combined with exposure with response prevention in OCD.

Methods: Sixty-one adults with OCD underwent rTMS and exposure with response prevention and were randomized to different high-frequency rTMS conditions: left dorsolateral prefrontal cortex (n = 19), left presupplementary motor area (n = 23), and control stimulation at the vertex at low intensity (n = 19).

View Article and Find Full Text PDF

Background: Repetitive transcranial magnetic stimulation (rTMS) is an emerging treatment for obsessive-compulsive disorder (OCD). The neurobiological mechanisms of rTMS in OCD have been incompletely characterized. We compared clinical outcomes and changes in task-based brain activation following 3 different rTMS protocols, all combined with exposure and response prevention.

View Article and Find Full Text PDF

Objective: To test a multifaceted treatment program for patients with obsessive-compulsive disorder (OCD) who did not respond to regular cognitive behavior therapy (CBT). The treatment addresses several factors that may play a role in maintaining OCD.

Methods: We designed a treatment consisting of a 6-day intensive, individual exposure in vivo with response prevention (ERP) format, with 24 therapist-assisted treatment hours at the patient's home and 12 self-controlled ERP hours, including behavioral activation and family interventions.

View Article and Find Full Text PDF

Mental health chatbots (MHCBs) designed to support individuals in coping with mental health issues are rapidly advancing. Currently, these MHCBs are predominantly used in commercial rather than clinical contexts, but this might change soon. The question is whether this use is ethically desirable.

View Article and Find Full Text PDF

Background: Taking patient preference into consideration has received increased attention in the last decades. We conducted a meta-analysis to estimate the effects of patient preference on clinical outcome, satisfaction and adherence regarding treatment of depression and anxiety.

Methods: Pubmed, Embase, PsycINFO and Scopus were searched for (cluster) randomized controlled trials.

View Article and Find Full Text PDF

Anxiety disorders are very prevalent and often persistent mental disorders, with a considerable rate of treatment resistance which requires regulatory clinical trials of innovative therapeutic interventions. However, an explicit definition of treatment-resistant anxiety disorders (TR-AD) informing such trials is currently lacking. We used a Delphi method-based consensus approach to provide internationally agreed, consistent and clinically useful operational criteria for TR-AD in adults.

View Article and Find Full Text PDF

Background: Depression in adolescents and young adults is common and causes considerable disease burden while hampering their development, leading to adverse consequences in later life. Although treatment is available, young people are a vulnerable group regarding uptake and completion of treatment. To improve this, insight into youth's preferences for treatment is essential.

View Article and Find Full Text PDF

Insomnia is common throughout the population and thought to be a risk factor for mental disorders. We assessed the association of insomnia symptoms with incidence, recurrence and persistence of mood, anxiety and substance use disorders. In 4007 participants (55 % women, mean age 51.

View Article and Find Full Text PDF

Dropout from psychological or pharmacological treatment for anxiety and depressive disorders is common. It is especially problematic in adolescents and young adults because of the adverse consequences for their development. Reasons for treatment dropout can be divided into therapy-process related factors, attitudinal aspects, and practical issues.

View Article and Find Full Text PDF

Background: Risk factors of a chronic course of anxiety and depressive disorders were previously studied using a limited definition of recovery, i.e. remission of the index disorder.

View Article and Find Full Text PDF

Background: Repetitive transcranial magnetic stimulation (rTMS) is an emerging treatment option for obsessive-compulsive disorder (OCD). The neurobiological mechanisms of rTMS in OCD have, however, been incompletely characterized. We compared clinical outcomes and changes in task-based brain activation following three different rTMS stimulation protocols, all combined with exposure and response prevention (ERP).

View Article and Find Full Text PDF

Background: Sleep gets little attention in mental health care treatments. Epidemiological research with regards to the association between sleep problems and anxiety and mood disorders can contribute to good clinical decision making.

Aim: Based on data from the Netherlands Mental Health Survey and Incidence Study-2 (NEMESIS-2), we examined the relation between sleep problems and first onset, recurrence and persistence of anxiety and mood disorders within a 3 year period.

View Article and Find Full Text PDF

Background: Both anxiety and depressive disorders are associated with significant long-term disability. Since experienced impairments vary between patients independent of diagnosis and disease severity, identifying transdiagnostic factors that predict the course of disability may provide new targets to reduce disability. This study examines transdiagnostic factors predicting the 2-year disability outcome in patients with anxiety and/or depressive disorders (ADD), focusing on potentially malleable factors.

View Article and Find Full Text PDF
Article Synopsis
  • Social anxiety disorder (SAD) can be effectively treated with cognitive behavioral therapy (CBT), but there is limited understanding of how symptom severity affects treatment outcomes.
  • This study aimed to investigate whether the severity of SAD symptoms at the start of therapy influences the degree of improvement after undergoing CBT.
  • The research included a meta-analysis of 12 studies with 1246 participants, revealing a significant reduction in symptoms from baseline to post-treatment when comparing CBT results to a waiting list control group.
View Article and Find Full Text PDF

Background: Shared decision making (SDM) is advised in the treatment guideline for depressive disorders. However, it’s unclear if SDM contributes to the optimization of care.

Aim: To provide an overview of the effects of SDM within the treatment of depression on treatment outcome, patient satisfaction and adherence through a meta-analysis and systematic review.

View Article and Find Full Text PDF
Article Synopsis
  • - Both antidepressant medication and running therapy are effective for treating depression and anxiety, but they might affect mental and physical health differently.
  • - In a study with 141 participants, remission rates after 16 weeks were similar for both treatments, but running therapy showed significant improvements in various physical health indicators like weight and blood pressure.
  • - The study had limitations, including a preference for running therapy among participants, which affected the sample size of each treatment group.
View Article and Find Full Text PDF

Background: Insomnia is the transdiagnostically shared most common complaint in disorders of anxiety, stress and emotion regulation. Current cognitive behavioral therapies (CBT) for these disorders do not address sleep, while good sleep is essential for regulating emotions and learning new cognitions and behaviours: the core fundaments of CBT. This transdiagnostic randomized control trial (RCT) evaluates whether guided internet-delivered cognitive behavioral therapy for insomnia (iCBT-I) (1) improves sleep, (2) affects the progression of emotional distress and (3) enhances the effectiveness of regular treatment of people with clinically relevant symptoms of emotional disorders across all mental health care (MHC) echelons.

View Article and Find Full Text PDF

Objective: Depression and anxiety in patients with an implantable cardioverter-defibrillator (ICD) are associated with adverse outcomes. This study describes the design of the PSYCHE-ICD study and evaluates the correlation between cardiac status and depression and anxiety in ICD patients.

Methods: We included 178 patients.

View Article and Find Full Text PDF